Phase I Evaluation of STA-1474, a Prodrug of the Novel HSP90 Inhibitor Ganetespib, in Dogs with Spontaneous Cancer

BACKGROUND: The novel water soluble compound STA-1474 is metabolized to ganetespib (formerly STA-9090), a potent HSP90 inhibitor previously shown to kill canine tumor cell lines in vitro and inhibit tumor growth in the setting of murine xenografts. The purpose of the following study was to extend th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: London, Cheryl A., Bear, Misty D., McCleese, Jennifer, Foley, Kevin P., Paalangara, Reji, Inoue, Takayo, Ying, Weiwen, Barsoum, James
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2011
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3207826/
https://ncbi.nlm.nih.gov/pubmed/22073242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0027018
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados